Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Zhujiang Hospital
Age
40–80
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
1. case group
1. Age from 40 to 80 years old; gender is not limited.
2. Stable COPD
3. Sign the informed consent with the willingness of obeying the protocol. -
1. Age from 40 to 80 years old; gender is not limited.
You may not be if
1. Subjects with known other chronic respiratory diseases except for COPD (such as asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al);
2. Subjects had been accepted lung lobectomy or transplantation;
3. Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al );
4. Alcoholism, drug or solvents addition;
5. Acute exacerbation COPD patients (AECOPD) -
<!-- -->
1. Subjects with known other chronic respiratory diseases (such as COPD, asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al);
2. Subjects had been accepted lung lobectomy or transplantation;
3. Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al );
4. Alcoholism, drug or solvents addition;
Clareo Health | Pilot Study on Proteomics of Erythrocyte Proteins in Patients With COPD Based on TMT Technology
